Navigation Links
New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus
Date:5/15/2008

Highest-risk precancerous condition of esophagus eliminated in 90 percent

of patients

SUNNYVALE, Calif., May 15 /PRNewswire/ -- BARRX Medical, Inc., the global technology leader for treating precancerous conditions of the digestive tract, today announced that 90.2 percent of the patients in a multi-center U.S. study were free of the highest-risk of Barrett's esophagus after having a non-surgical, endoscopic treatment using the HALO360 ablation system. Barrett's esophagus afflicts more than three million U.S. adults and is a complication of gastroesophageal reflux disease (GERD). The abnormal Barrett's tissue is the precursor to esophageal cancer (adenocarcinoma), which has the fastest rising incidence of all cancers in the U.S.

This study is currently online and appearing in an upcoming issue of Gastrointestinal Endoscopy, a medical journal for gastroenterologists who perform advanced diagnostic and therapeutic endoscopic procedures. In the report titled, "Circumferential Ablation of Barrett's Esophagus Containing High-Grade Dysplasia: A U.S. Multi-Center Registry," 142 patients with the most advanced stage of Barrett's esophagus -- called high grade dysplasia -- were treated with the HALO360 Ablation System and had a 90.2% clearance rate. This unique, catheter-based technology applies a controlled amount of heat energy to the diseased tissue of the esophagus, resulting in restoration of a normal esophageal lining in the majority of patients.

"The results of our trial confirm that this sub-type of Barrett's esophagus having the highest-risk of becoming cancer can be safely and effectively treated," said Abbott Northwestern Chief of Gastroenterology and Associate Professor of Medicine, Robert Ganz, M.D., of Minneapolis, MN. Dr. Ganz led the study which was co-authored with specialists at 15 other leading U.S. medical centers. "We're confident this treatment can sharply reduce the number of patients who have a
'/>"/>

SOURCE BARRX Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/17/2014)... Dec. 17, 2014   Synageva BioPharma Corp. ... therapeutic products for rare disorders, announced today its presentation ... in San Francisco, CA. ... Executive Officer, will present on Monday, January 12, 2015, ... will be webcast live and may be accessed from ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... SHANGHAI, China, Jan. 31 /Xinhua-PRNewswire/ -- WuXi ... its acquisition of AppTec Laboratory,Services, Inc., a ... device industries. AppTec offers testing, contract research ... a highly,differentiated, fully integrated platform., (Logo: ...
... (Nasdaq: DRRX ) fourth quarter 2007 financial,results press release, you ... live over the Internet on Wednesday, February 6,2008 at 9:00 a.m. ... 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST). Where: ... http://www.durect.com, ...
... AMLN ) will be presenting at the Merrill ... York on,Wednesday, February 6, 2008 at 1:00 p.m. ET ... Finance and Chief Financial Officer of,Amylin Pharmaceuticals, will be ... breakout session will be webcast, and a,recording will be ...
Cached Biology Technology:WuXi PharmaTech Completes Acquisition of AppTec 2
(Date:11/18/2014)...  The Secure Identity & Biometrics Association (SIBA) ... the formation of The Airport Entry and Exit ... and Biometric Entry and Exit Solutions Framework for ... from BORDERPOL, the international non-profit organization that works ... regarding border security, traveler and migration systems. ...
(Date:11/18/2014)... -- The Parenteral Drug Association (PDA) today confirmed that seven ... at least seven more will participate in the upcoming 2014 ... in Washington D.C. , Dec. 2-4. ... from the regulatory agencies in the United States ... effort to help advance the use of metrics in the ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still be ... McCoy used in "Star Trek" to gain instant access to ... to work with smartphones and tablets for monitoring and measuring ... healthcare world. This may seem a tad Orwellian to some, ... adopt some of these technological opportunities into their healthcare regime. ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... Department of Agriculture; and the University of Haifa in Israel ... protein, zinc and iron content in the grain, potentially offering ... children around the world. , Results from the study will ... Science. , "Wheat is one of the world's major ...
... pictures made the cover of Nature in 1998, were ... appears, they may have been. , This week, a ... reinterpreting the 600 million-year-old fossils from the Precambrian era ... understanding of microfossils thought to be the oldest animals," ...
... hunts begin in the Japanese villages of Taiji and Futo, ... has launched a campaign to end the practices through public ... put an end to the hunts. The "Act for Dolphins" ... and the World Association of Zoos and Aquariums (WAZA) --maintains ...
Cached Biology News:Wheat gene may boost foods' nutrient content 2Oldest animal fossils may have been bacteria 2Renewed dolphin slaughter prompts new campaign 2Renewed dolphin slaughter prompts new campaign 3
Gap junction protein, beta 2, 26kDa (connexin 26) Antigen: Peptide...
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2...
HSPBP1 Antibody...
... CRE-bla HEK 293T cell line contains the ... cAMP response element (CRE). To obtain the ... into HEK 293T cells by lentivirus. Subsequent ... responsive to forskolin stimulation (Figure 1). The ...
Biology Products: